Free Trial

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health logo
$156.55 +1.36 (+0.88%)
Closing price 03:59 PM Eastern
Extended Trading
$157.73 +1.18 (+0.75%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
3
Buy
12

Based on 15 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 3 have given a hold rating, and 12 have given a buy rating for CAH.

Consensus Price Target

$166.00
6.03% Upside
According to the 15 analysts' twelve-month price targets for Cardinal Health, the average price target is $166.00. The highest price target for CAH is $203.00, while the lowest price target for CAH is $124.00. The average price target represents a forecasted upside of 6.03% from the current price of $156.55.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAH Analyst Ratings Over Time

TypeCurrent Forecast
10/7/24 to 10/7/25
1 Month Ago
9/7/24 to 9/7/25
3 Months Ago
7/9/24 to 7/9/25
1 Year Ago
10/8/23 to 10/7/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
7 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$166.00$165.93$157.43$119.36
Forecasted Upside6.03% Upside11.01% Upside-4.19% Downside6.81% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cardinal Health Stock vs. The Competition

TypeCardinal HealthMedical CompaniesS&P 500
Consensus Rating Score
2.80
2.33
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside6.93% Upside1,285.12% Upside170.53% Upside
News Sentiment Rating
Positive News

See Recent CAH News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/6/2025Leerink Partners
1 of 5 stars
Michael Cherny
Michael Cherny
Not Rated
Boost TargetOutperform$186.00 ➝ $187.00+21.05%
9/27/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingBuy (B)
8/22/2025Argus
4 of 5 stars
 Set Target$189.00+28.15%
8/13/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$183.00 ➝ $185.00+26.27%
8/13/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$200.00 ➝ $190.00+29.68%
8/13/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$197.00 ➝ $203.00+38.56%
8/12/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Target$150.00-5.10%
8/12/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
8/12/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
6/13/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$157.00 ➝ $170.00+5.97%
6/10/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$165.00 ➝ $170.00+10.65%
3/31/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$142.00 ➝ $150.00+9.95%
2/4/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$142.00 ➝ $145.00+13.97%
1/8/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldBuy$130.00 ➝ $144.00+18.90%
11/4/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetHold$119.00 ➝ $124.00+9.48%
11/4/2024Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$117.00 ➝ $133.00+14.53%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:33 PM ET.


Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, October 5, 2025. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • The current stock price is around $150, which may present a buying opportunity for investors looking for value in the healthcare sector.
  • Cardinal Health, Inc. recently reported earnings that exceeded analysts' expectations, indicating strong operational performance and potential for future growth.
  • The company has a solid market capitalization of approximately $37 billion, suggesting stability and a significant presence in the healthcare market.
  • With a dividend yield of 1.3%, Cardinal Health, Inc. offers a reliable income stream for investors, which is particularly appealing in uncertain market conditions.
  • The firm has set ambitious earnings guidance for FY 2026, projecting EPS between 9.300 and 9.500, which could signal future profitability and growth potential.

Cardinal Health
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • The company has a negative return on equity of 74.45%, which may raise concerns about its ability to generate profit from shareholders' investments.
  • Cardinal Health, Inc. reported a net margin of only 0.70%, indicating that the company retains a small portion of its revenue as profit, which could limit growth potential.
  • Despite a slight year-over-year revenue increase, the company fell short of analysts' revenue expectations, which may suggest challenges in meeting market demands.
  • The stock has experienced significant price fluctuations, with a one-year high of $168.44 and a low of $106.98, indicating volatility that could deter risk-averse investors.
  • The company's PEG ratio of 1.34 suggests that the stock may be overvalued relative to its growth rate, which could be a red flag for potential investors.

CAH Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $166.00, with a high forecast of $203.00 and a low forecast of $124.00.

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 3 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CAH shares.

According to analysts, Cardinal Health's stock has a predicted upside of 6.03% based on their 12-month stock forecasts.

Cardinal Health has been rated by research analysts at Argus, Evercore ISI, Jefferies Financial Group, Leerink Partners, Morgan Stanley, Robert W. Baird, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Cardinal Health more than other "medical" companies. The consensus rating for Cardinal Health is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CAH compares to other companies.


This page (NYSE:CAH) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners